It is well documented that hyperuricemia is an independent risk factor for IgA nephropathy, and appropriate treatment by allopurinol is a reasonable modality in the patients. We believe that, this drug should routinely be included to the treatment of patients with IgA nephropathy. In this regard, to better understand the allopurinol kidney protective properties in IgA nephropathy, clinical studies are suggested
